Cost Effectiveness
VIDEO: Robotic assistance may be warranted for complex adult spinal deformity surgery
LAS VEGAS — In this video from the American Academy of Orthopaedic Surgeons Annual Meeting, Andrew J. Schoenfeld, MD, discussed the cost-utility benefits of robotic assistance for adult spinal deformity procedures.
Web-based follow-up care may be safe, cost-effective for THA, TKA
KOLOA, Hawaii — Web-based follow-up care for routine total hip and knee arthroplasty may be cost-effective and safe, but requires some work for implementation, according to a presenter at Orthopedics Today Hawaii.
Cancer drugs approved based on OS vs. surrogate outcomes have lowest median annual cost
Cancer drugs that received approval based on increased OS compared with other measures had the lowest median annual cost, according to a research letter published in JAMA Internal Medicine.
Cement augmentation may yield cost savings, QALY gains in unstable trochanteric fractures
Published results showed fixation with the use of cement augmentation may lead to cost savings and quality-adjusted life-year gains in patients with unstable trochanteric fractures compared with fixation without augmentation.
AF screening may lower cost, increase QALYs in older adults
Atrial fibrillation screening in older patients in Sweden was associated with lower cost after 3 years and a gain in quality-adjusted life-years compared with not screening, according to data published in the European Heart Journal.
Ramping up HCV elimination tactics could save 90,000 lives, $60 billion by 2050
WASHINGTON — An accelerated, nationally organized plan to eliminate hepatitis C virus in the United States could save more than 90,000 lives and nearly $60 billion by 2050, according to a health economics expert at The Liver Meeting.
Response-adapted immunotherapy cost-effective, may push melanoma to ‘individualized care’
Response-adapted therapy in melanoma, which involves removal of certain immunotherapeutic agents in a combination, can reduce costs without a decrease in efficacy, according to a study.
Dapagliflozin seen as cost-effective for CKD in the United Kingdom, Germany, Spain
In the United Kingdom, Germany and Spain, dapagliflozin with standard therapy is a cost-effective treatment for chronic kidney disease, according to data published in the Clinical Journal of the American Society of Nephrology.
Further study needed on cost-effectiveness of teprotumumab for thyroid eye disease
CHICAGO — Commercial insurer payments for teprotumumab vary dramatically, with cost influencing access to care and cost-effectiveness, according to a study presented at the ASOPRS Fall Scientific Symposium.
InterWell Health, Cricket Health, Fresenius Health Partners complete merger
The three-way merger of InterWell Health, Cricket Health and Fresenius Health Partners has been completed, according to a press release.